» Articles » PMID: 2841610

T Cells Can Present Antigens Such As HIV Gp120 Targeted to Their Own Surface Molecules

Overview
Journal Nature
Specialty Science
Date 1988 Aug 11
PMID 2841610
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

To trigger class II-restricted T cells, antigen presenting cells have to capture antigens, process them and display their fragments in association with class II molecules. In most species, activated T cells express class II molecules; however, no evidence has been found that these cells can present soluble antigens. This failure may be due to the inefficient capture, processing or display of antigens in a stimulatory form by T-cells. The capture of a soluble antigen, which is achieved by nonspecific mechanisms in macrophages and dendritic cells, can be up to 10(3) times more efficient in the presence of surface receptors, such as surface immunoglobulin on B cells that specifically bind antigen with high affinity. We asked whether T cells would be able to present soluble antigens that bind to their own surface molecules. Here we show that such antigens can be effectively processed and presented by both CD4+- and CD8+-bearing human T cells. This indicates that T cells are fully capable of processing and displaying antigens and are mainly limited in antigen presentation by their inefficiency at antigen capture.

Citing Articles

Application of deep learning models on single-cell RNA sequencing analysis uncovers novel markers of double negative T cells.

Xu T, Xu Q, Lu R, Oakland D, Li S, Li L Sci Rep. 2024; 14(1):31158.

PMID: 39732739 PMC: 11682054. DOI: 10.1038/s41598-024-82406-7.


Mapping the dynamic genetic regulatory architecture of HLA genes at single-cell resolution.

Kang J, Shen A, Gurajala S, Nathan A, Rumker L, Aguiar V Nat Genet. 2023; 55(12):2255-2268.

PMID: 38036787 PMC: 10787945. DOI: 10.1038/s41588-023-01586-6.


Harnessing Autophagy to Overcome Antigen-Specific T-Cell Dysfunction: Implication for People Living with HIV-1.

Ghahari N, Telittchenko R, Loucif H, Isnard S, Routy J, Olagnier D Int J Mol Sci. 2023; 24(13).

PMID: 37446195 PMC: 10342174. DOI: 10.3390/ijms241311018.


Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation.

Cieniewicz B, Bhatta A, Torabi D, Baichoo P, Saxton M, Arballo A Mol Ther. 2023; 31(7):2132-2153.

PMID: 37194236 PMC: 10362418. DOI: 10.1016/j.ymthe.2023.05.009.


Mapping the dynamic genetic regulatory architecture of genes at single-cell resolution.

Kang J, Shen A, Sakaue S, Luo Y, Gurajala S, Nathan A medRxiv. 2023; .

PMID: 36993194 PMC: 10055604. DOI: 10.1101/2023.03.14.23287257.